Hematology/Oncology News

CHICAGO — “Lift as you climb” in medicine and take the time to build relationships, according to Kimberly Manning, MD, FACP, FAAP.

Breastfeeding appeared safe in women with hormone receptor–positive early breast cancer who temporarily interrupted treatment to attempt pregnancy, according to results from the POSITIVE trial presented at ESMO Congress.

Photon and proton beam radiation therapies conferred similar outcomes for men with localized prostate cancer, according to results of a randomized phase 3 trial.

A randomized phase 2 trial of individuals with cancer cachexia showed those assigned ponsegromab gained significantly more weight than those assigned placebo.

Women who want breast reconstruction after mastectomy can undergo a shorter radiation therapy regimen without significantly increasing their risk for complications, according to results of a randomized phase 3 trial.

A randomized phase 3 trial designed to compare an investigational combination with standard care for certain patients with advanced colorectal cancer failed to meet its primary endpoint of OS.

Older adults undergoing cancer treatment exhibited reduced risk for falling if they had discussions about physical activity with their health care provider, according to study results.

September is Gynecologic Cancer Awareness Month.

Adults diagnosed with endogenous Cushing’s syndrome have a higher risk for developing cancer compared with controls without the condition, according to data published in the European Journal of Endocrinology.

ORLANDO, Fla. — An analysis of the gut microbiome among individuals who survived cancer revealed a significant association between the gut-brain axis, particularly in gut microbiota, metabolism and cognitive function, according to a poster.